Healthcare Matters
State of Healthcare in Spain
Alfonso Aguarón Turrientes
AEAL, Spanish Group of People Affected by Lymphoma, Myeloma and Leukemia
The outlook of economic crisis in Spain has resulted in the current Government adopting a set of measures and decisions focused on the search of solutions. Many of them are not supported by the vast majority of the population because they seriously affect some social rights.
Read more
LATEST LYMPHOMA NEWS
New Hope for T-cell Lymphoma
Until recently, patients with T-cell lymphoma have been treated with the same treatments used for B-cell lymphoma. Unfortunately, this approach has not resulted in enduring remissions for those with T-cell lymphoma.
Read more...NHL & Quality of Life
Being a long-term survivor of non-Hodgkin lymphoma can have a negative impact on quality of life (QoL). In a follow-up to an earlier survey, it was found that while 32% of respondents reported persistently high of improved QoL, 42% reported persistently low of worsening QoL.
Read more...
WHAT’S HAPPENING AROUND THE WORLD
-
Ireland-Plea on Cancer Patients' Fuel Bills
Almost 40% of cancer patients in Northern Ireland cannot afford to pay their winter fuel bills, a new report claims.
Many are struggling to meet financial commitments such as travel for medical appointments,
Read more... -
Curability of Advanced FL
The three articles linked below are an interesting discussion about the curability of follicular lymphoma. Whether or not some patients can be cured may come down to being able to identify the optimal therapy for each individual patient. Read the discussion by clicking on the links below.
Read more...
RESEARCH
-
Advanced FL treatment
Selecting the appropriate first-line treatment for patients with follicular non-Hodgkin lymphoma (FL) has been the source of both debate and controversy for the last 40 years. However, results from four large phase III randomised studies
Read more... -
Radioimmunotherapy and Follicular Lymphoma
Two studies have examined the use of radioimmunotherapy (RIT) in follicular lymphoma (FL). Both studies enrolled patients in need of therapy. In the first study, RIT was administered as a single agent.
Read more...
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.
Upcoming Events
- Board Meeting - Tue. 21 May, 2013 Meetings
- LLS - Living with Slow-Growing Lymphoma - Tue. 21 May, 2013 Education Sessions
- LLS - PTCL - Diagnosis & Treatment Update - Wed. 29 May, 2013 Education Sessions
